Health Canada issues advisory on potential Pulmicort Turbuhaler device failure

Health Canada has issued an advisory to health care professionals that “AstraZeneca Canada has received a small number of product complaints for Pulmicort Turbuhaler, 200 µg per metered dose (200 doses) regarding the malfunction of the delivery device that results in a failure to dispense the dose of medication.” According to the notice, the devices sometimes fail to load a dose.

The agency reminds clinicians to tell patients to listen for a click indicating proper loading of the dose after they twist the grip on the device before inhalation.

Read the Health Canada/AstraZeneca notice.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan